Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Salivary Gland Neoplasms 1Melanoma 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Hodgkin Disease 1Epstein-Barr Virus Infections 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4Paclitaxel 3Docetaxel 3Taxes 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Gemcitabine 2Carboplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1mercaptoundecahydrododecaborate 1bicalutamide 1Vorinostat 1Triptorelin Pamoate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pilocarpine 1Methotrexate 1Irinotecan 1In Situ Hybridization 1Erlotinib Hydrochloride 1Doxorubicin 1Chemotherapy, Adjuvant 1CP protocol 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × In Situ Hybridization × Clear all
NCT01487733 2017-05-17

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Eastern Cooperative Oncology Group

Completed
155 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡